Allergan, Inc.

Case [2012] APO 48


IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

Allergan, Inc. [2012] APO 48

Patent Application:                   2010249170

Title:Needleless injectors

Patent Applicant:  Allergan, Inc.

Delegate:  E J Knock

Decision Date:  2 May 2012

Catchwords:  PATENTS – examiner objection – case management of divisional applications – no response by applicant – application refused

Representation:  Patent applicant:  Anthony J Cowle, Davies Collison Cave, Sydney

IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

Patent Application:                   2010249170   

Title:Needleless injectors

Patent Applicant:  Allergan, Inc.

Date of Decision:  2 May 2012

DECISION

I refuse the application.

REASONS FOR DECISION

Patent application 2010249170 was filed by Allergan, Inc. as a divisional of application 2004249238 on 3 December 2010.  An examination report issued on 15 December 2011, raising five objections.  In line with the Commissioner's approach to case management of divisionals, the report included the following note:

“Objection(s) 2 and 4 of my report are based on the same grounds objected to in the examination of patent application 2004249238. Please note that if a response overcoming this objection is not filed within two months of the date of this report the Commissioner will consider whether to direct amendment of the application under section 107 or proceed to refuse the application under section 49(2) of the Act. If you intend to proceed under either of these provisions the Commissioner will notify you in writing and indicate the time and place you may be heard on the matter. In deciding the matter the Commissioner will consider all possible grounds of objection to the application not only those identified above."

As no reply was received, the Commissioner issued a hearing notice in the following terms:

"The examination report of 15 December 2011 raised an objection(s) equivalent to that in the parent application.  In line with our approach to case management of divisionals, you were given two months to respond to that report.  As no response has been received, the matter will now be set for hearing.

I believe that it is possible to hear this matter on the basis of written submissions, so I allow you one (1) month from the date of this letter to file any submissions you wish.  Your submissions should address the ground(s) of objection identified in the examination report.  Once your submissions have been received, or alternatively if no submissions are received, the matter will be passed to a hearing officer to issue a written decision.  Please note that it is possible for the Commissioner to refuse the application or direct amendment.

Alternatively, if you file amendments overcoming the objection(s) within this period, the Commissioner will not proceed with the hearing.  However, if the amendments do not fully overcome the objection(s), you will be advised of this fact and the hearing may continue as above."

The applicant has not provided any submissions.

The objection

I have reviewed the examiner's report, and I agree that there are appropriately raised objections.  The applicant has chosen not to defend the application.  They have provided no submissions disputing the objections, and have not proposed any amendment to attempt to overcome the objections.  In these circumstances there are no reasonable prospects of the applicant overcoming the objections.  The application should be refused.

E J Knock
Delegate of the Commissioner of Patents

Details
AGLC
Allergan, Inc. [2012] APO 48
Case
[2012] APO 48
Decision Date

CaseChat Overview and Summary

Allergan, Inc. applied for a patent for a needleless injector. The application was a divisional of a previous application. An examination report was issued on 15 December 2011, raising five objections to the application. A further report was issued on 24 February 2012, allowing the applicant a month to provide submissions or amendments in response to the objections. Allergan, Inc. did not respond to either report, and no submissions or amendments were received by the Commissioner. The Commissioner considered the objections were valid and refused the application.

The central issue in this case was whether the objections raised in the examination report were valid and whether the applicant had done enough to overcome them. The Commissioner found that the objections were valid and that the applicant had not provided any submissions or amendments to address the objections.

In reaching their decision, the Commissioner noted that the applicant had been given sufficient time to respond to the examination report and to provide submissions or amendments to overcome the objections. The Commissioner also noted that the applicant had not proposed any amendments to overcome the objections, and that there were no reasonable prospects of the applicant overcoming the objections. The Commissioner therefore refused the application.

The Commissioner refused the application for a patent for a needleless injector.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.